Prevalence of Hypogonadism in Males Aged at Least 45 Years: the HIM Study

Overview

Journal Int J Clin Pract

Publisher Wiley

Specialty General Medicine

Date 2006 Jul 19

PMID 16846397

Citations 207

Authors

T Mulligan

M F Frick

Q C Zuraw

A Stemhagen

C McWhirter

Affiliations

Soon will be listed here.

Abstract

The Hypogonadism in Males study estimated the prevalence of hypogonadism [total testosterone (TT) < 300 ng/dl] in men aged > or = 45 years visiting primary care practices in the United States. A blood sample was obtained between 8 am and noon and assayed for TT, free testosterone (FT) and bioavailable testosterone (BAT). Common symptoms of hypogonadism, comorbid conditions, demographics and reason for visit were recorded. Of 2162 patients, 836 were hypogonadal, with 80 receiving testosterone. Crude prevalence rate of hypogonadism was 38.7%. Similar trends were observed for FT and BAT. Among men not receiving testosterone, 756 (36.3%) were hypogonadal; odds ratios for having hypogonadism were significantly higher in men with hypertension (1.84), hyperlipidaemia (1.47), diabetes (2.09), obesity (2.38), prostate disease (1.29) and asthma or chronic obstructive pulmonary disease (1.40) than in men without these conditions. The prevalence of hypogonadism was 38.7% in men aged > or = 45 years presenting to primary care offices.

Citing Articles

Impact of noninsulin-dependent diabetes mellitus (level of control) on sex hormone profile and erectile function.

Khawaji A, El-Tholoth H, Albarakati M, Binjabaan B, Alzahrani A, Althobity A Urol Ann. 2025; 17(1):52-57.

PMID: 40051993 PMC: 11881944. DOI: 10.4103/ua.ua_40_24.

Gonadal Hormone Changes with Aging and Their Impact on Chronic Pain.

Athnaiel O, Davidson N, Mangat J, Nasr N, Knezevic N Cells. 2025; 14(2).

PMID: 39851551 PMC: 11763711. DOI: 10.3390/cells14020123.

Association of total testosterone levels with cardiometabolic diseases in men with erectile dysfunction.

Chen B, Tsai P, Jiann B Sex Med. 2025; 12(6):qfae089.

PMID: 39801930 PMC: 11723798. DOI: 10.1093/sexmed/qfae089.

Association Between Type 2 Diabetes and Hypogonadism in India: An Observational Study.

Unnikrishnan A, Saboo B, Majumdar A, Saraogi R, Sundar S, Mahadevan S Indian J Endocrinol Metab. 2024; 28(5):473-479.

PMID: 39676785 PMC: 11642515. DOI: 10.4103/ijem.ijem_262_23.

Association between serum cotinine and total testosterone in adult males based on NHANES 2011-2016.

Liu M, Gou Y, Zou B, Li X, Yang P Sci Rep. 2024; 14(1):23042.

PMID: 39362996 PMC: 11450214. DOI: 10.1038/s41598-024-74482-6.

References

Kubricht 3rd W, Williams B, Whatley T, Pinckard P, Eastham J . Serum testosterone levels in African-American and white men undergoing prostate biopsy. Urology. 1999; 54(6):1035-8. DOI: 10.1016/s0090-4295(99)00290-3. View

Lethbridge-Cejku M, Schiller J, Bernadel L . Summary health statistics for U.S. adults: National Health Interview Survey, 2002. Vital Health Stat 10. 2005; (222):1-151. View

Harman S, Metter E, Tobin J, Pearson J, Blackman M . Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab. 2001; 86(2):724-31. DOI: 10.1210/jcem.86.2.7219. View

Vermeulen A . Androgen replacement therapy in the aging male--a critical evaluation. J Clin Endocrinol Metab. 2001; 86(6):2380-90. DOI: 10.1210/jcem.86.6.7630. View

Feldman H, Longcope C, Derby C, Johannes C, Araujo A, Coviello A . Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab. 2002; 87(2):589-98. DOI: 10.1210/jcem.87.2.8201. View

Gapstur S, Gann P, Kopp P, Colangelo L, Longcope C, Liu K . Serum androgen concentrations in young men: a longitudinal analysis of associations with age, obesity, and race. The CARDIA male hormone study. Cancer Epidemiol Biomarkers Prev. 2002; 11(10 Pt 1):1041-7. View

Delhez M, Hansenne M, Legros J . Andropause and psychopathology: minor symptoms rather than pathological ones. Psychoneuroendocrinology. 2003; 28(7):863-74. DOI: 10.1016/s0306-4530(02)00102-6. View

Szulc P, Claustrat B, Marchand F, Delmas P . Increased risk of falls and increased bone resorption in elderly men with partial androgen deficiency: the MINOS study. J Clin Endocrinol Metab. 2003; 88(11):5240-7. DOI: 10.1210/jc.2003-030200. View

Shores M, Sloan K, Matsumoto A, Moceri V, Felker B, Kivlahan D . Increased incidence of diagnosed depressive illness in hypogonadal older men. Arch Gen Psychiatry. 2004; 61(2):162-7. DOI: 10.1001/archpsyc.61.2.162. View

10.

Petak S, Nankin H, Spark R, Swerdloff R, Rodriguez-Rigau L . American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the evaluation and treatment of hypogonadism in adult male patients--2002 update. Endocr Pract. 2004; 8(6):440-56. View

11.

Kelleher S, Conway A, Handelsman D . Blood testosterone threshold for androgen deficiency symptoms. J Clin Endocrinol Metab. 2004; 89(8):3813-7. DOI: 10.1210/jc.2004-0143. View

12.

Amatruda J, Harman S, Pourmotabbed G, Lockwood D . Depressed plasma testosterone and fractional binding of testosterone in obese males. J Clin Endocrinol Metab. 1978; 47(2):268-71. DOI: 10.1210/jcem-47-2-268. View

13.

Zumoff B, Strain G, Miller L, Rosner W, Senie R, Seres D . Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab. 1990; 71(4):929-31. DOI: 10.1210/jcem-71-4-929. View

14.

Gray A, Feldman H, McKinlay J, Longcope C . Age, disease, and changing sex hormone levels in middle-aged men: results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 1991; 73(5):1016-25. DOI: 10.1210/jcem-73-5-1016. View

15.

Belanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez J . Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. J Clin Endocrinol Metab. 1994; 79(4):1086-90. DOI: 10.1210/jcem.79.4.7962278. View

16.

Brambilla D, McKinlay S, McKinlay J, Weiss S, Johannes C, Crawford S . Does collecting repeated blood samples from each subject improve the precision of estimated steroid hormone levels?. J Clin Epidemiol. 1996; 49(3):345-50. DOI: 10.1016/0895-4356(95)00569-2. View

17.

Morley J, Kaiser F, Perry 3rd H, Patrick P, Morley P, Stauber P . Longitudinal changes in testosterone, luteinizing hormone, and follicle-stimulating hormone in healthy older men. Metabolism. 1997; 46(4):410-3. DOI: 10.1016/s0026-0495(97)90057-3. View

18.

McLachlan R, Allan C . Defining the prevalence and incidence of androgen deficiency in aging men: where are the goal posts?. J Clin Endocrinol Metab. 2004; 89(12):5916-9. DOI: 10.1210/jc.2004-2035. View

19.

Araujo A, ODonnell A, Brambilla D, Simpson W, Longcope C, Matsumoto A . Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2004; 89(12):5920-6. DOI: 10.1210/jc.2003-031719. View

20.

Asbell S, Raimane K, Montesano A, Zeitzer K, Asbell M, Vijayakumar S . Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients. J Natl Med Assoc. 2000; 92(9):445-9. PMC: 2608532. View